Montelukast Sodium Tablet, Film Coated
Product Images NDC 67296-1926

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 67296-1926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (Montelukast 10mg 30)

Principal Display Panel (Montelukast 10mg 30)
This text provides information about a medication that contains 10.4 mg of Montelukast Sodium USP, which is equivalent to 10 mg of Montelukast. The usual dosage instructions are not provided, so it recommends referring to the accompanying Prescribing Information. The storage conditions are specified as between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It is advised to protect the medication from moisture and light and store it in the original package. Additionally, there is mention of a medication guide available online. The manufacturer is specified as Accord Healthcare, Inc. in Durham, NC, and the tablets are manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India. The text indicates that the tablets are for adults aged 15 years and older, and it is available by prescription only. The NDC number is provided as 16729-119-10, and the package contains 30 tablets.*
FDA Label Image

Image Of Figure 1 (Montelukast Fig1)

Image Of Figure 1 (Montelukast Fig1)
This text appears to show a table displaying the mean percent change from baseline for a study involving treatment with Montelukast Sodium Tablets. The table includes time periods in weeks and corresponding percentage values. The data seems to be related to the effectiveness or impact of the treatment over the specified weeks.*
FDA Label Image

Image Of Chemical Structure (Montelukast Str)

Image Of Chemical Structure (Montelukast Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.